Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized BromAc for mechanically ventilated adults with pneumonia
RBR-586qvsjPhase 2Recruiting
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Jun 2025
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of BromAc, bromelain and acetylcysteine in pneumonia (4 arms), sponsored by Universidade Federal de Minas Gerais. Started Jun 2025; status: recruiting.
02
Drugs
BromAcbromelainacetylcysteine
03
Conditions
pneumonia
Beyond the preview
Go deeper on RBR-586qvsj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-586qvsj.